Pil-Soo Sung

53PUBLICATIONS
96CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersDisease surveillanceAutoimmunityImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Aug 04, 2026
Comparison of Second-line Hepatic Arterial Infusion Chemotherapy and Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma.

|Feb 27, 2026
Shelterin Component TPP1 Drives Tumor Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma.

Jung Eun Jang, Hye Seon Kim, Jin Seoub Kim

|Jan 14, 2026
Challenges of an EMR-Based Hospital Alert Program for Micro-Elimination of Hepatitis C in Tertiary Referral Hospitals.

Hee Yeon Kim, Hae Lim Lee, Heechul Nam

|Dec 30, 2025
Prognostic Significance of Glypican-3 Expression in Hepatocellular Carcinoma Treated with Atezolizumab-Bevacizumab.

Ji Hoon Kim, Ji Won Han, Hee Sun Cho

|Dec 09, 2025
Expanded but dysfunctional regulatory T cells in treatment-naïve autoimmune hepatitis.

Mi Hyun Kwon, Eun Ji Jang, Kwon Yong Tak

|Jul 21, 2025
The PNPLA3 I148M variant is associated with immune cell infiltration and advanced fibrosis in MASLD: a prospective genotype-phenotype study.

Jaejun Lee, Jung Hoon Cha, Hee Sun Cho

Pageof 9

Frequent Collaborators

26 joint publications

Seung-Kew Yoon

26 joint publications

Jeong-Won Jang

23 joint publications

Ji-Won Han

19 joint publications

Si-Hyun Bae